What is BG stock price target for 2026?

WallStSmart's 12-month price target for Bunge Limited is $122.99, representing 2.6% downside from the current price of $126.31.

What is BG stock forecast?

Bunge Limited forecast includes bull, base, and bear case scenarios from 2026 through 2030. Revenue and EPS projections are derived from analyst consensus and conservative extrapolation with growth deceleration for outer years.

Is BG undervalued based on price targets?

Our DCF intrinsic value for Bunge Limited is $155.26, against a current price of $126.31. The margin of safety is 21.40%.

Bunge Limited

NYSE: BG · CONSUMER DEFENSIVE · FARM PRODUCTS

$126.31

-0.04% today

Updated 2026-04-29

Market cap

$24.48B

P/E ratio

33.24

P/S ratio

0.35x

EPS (TTM)

$3.80

Dividend yield

—

52W range

$70 – $132

Volume

1.7M

Market cap

$24.48B

P/E ratio

33.24

P/S ratio

0.35x

EPS (TTM)

$3.80

Dividend yield

—

52W range

$70 – $132

Volume

1.7M

Bunge Limited (BG) Financial Forecast & Price Target 2030

Research-backed projections from analyst consensus, management guidance, and sector analysis.

Price target summary

Current

$126.31

Consensus

$132.29

+4.73%

2030 Target

—

DCF

$155.26

+21.40% MoS

Current price

$126.31

Analyst consensus

$132.29

+4.73%

2030 Target

—

Intrinsic (DCF)

$155.26

+21.40% MoS

7 analysts:

5 Buy1 Hold0 Sell

Management guidance

Bunge management targets $15 adjusted EPS by 2030 (up from $7.57 in 2025), representing ~98% EPS growth over 5 years. This guidance is supported by Viterra integration synergies, IFF protein acquisition, and strategic growth initiatives announced at the March 2026 Investor Day. No specific revenue targets were disclosed, but management signaled confidence in mid-cycle earnings power through operational leverage and margin expansion.

Sources: Management guidance, analyst consensus, sector analysishigh confidence

Revenue & price projection

Actual revenue Projected revenue Base case Bull to bear range

Bull case (2030)

$11,518.38

—

Base case (2030)

$6,911.03

—

Bear case (2030)

$4,607.35

—

Financial forecast — research-backed

Metric	2023	2024	2025	2026 (E)	2027 (E)	2028 (E)
Revenue	$59.5B	$53.1B	$70.3B	$95.8B	$104.2B	$111.5B
Revenue growth	—	-10.8%	32.4%	36.2%	8.7%	7.0%
EPS	$13.67	$9.19	$7.38	$8.29	$10.24	$12.15
P/S ratio	—	—	—	12.0x	12.0x	12.0x
Implied price	—	—	—	$5,940.38	$6,458.06	$6,911.03

Catalysts & risks

Growth catalysts

+ Viterra Limited integration and $500M+ cumulative run-rate cost synergies (3-year target through 2028)

+ IFF soy protein, lecithin, and crush business acquisition completion driving margin accretion

+ Shareholder capital allocation: $3B buyback program + 50% excess FCF return target supporting EPS growth

+ $15 adjusted EPS target by 2030 implying significant operational leverage and earnings expansion

Key risks

- Commodity price volatility and margin compression in grain/oilseed trading (1.2% current profit margin)

- Limited management visibility on 2026+ market conditions per Q4 2025 earnings call

- Viterra integration execution risk and potential synergy realization delays

- Regulatory pressures on agricultural inputs and sustainability reporting requirements

- Working capital intensity and leverage management (1.0x Debt/Equity, 22.69x EV/EBITDA)

Methodology

Bunge Limited's forward estimates are derived from AI-powered research synthesis combining analyst consensus from 7 Wall Street analysts, management guidance from the latest earnings call, and sector growth forecasts from industry research. Revenue and EPS projections use analyst consensus where available and conservative extrapolation with growth deceleration for outer years. Price targets are calculated using a tiered Price-to-Sales (P/S) methodology, where the P/S multiple is determined by the projected revenue growth rate.

WallStSmart proprietary research model · Not financial advice · Past performance is not indicative of future results · Last researched: April 7, 2026.